Samsung acquires French AI medtech start-up Sonio

Samsung Medison has signed an agreement to acquire 100 per cent of the shares of the French foetal ultrasound AI software company Sonio.

Sonio has developed an “AI-powered” solution for obstetrics and gynaecology ultrasound that aims to assist medical professionals in the evaluation and documentation of ultrasound exams.

Sonio Detect, the company’s AI assistant, uses deep learning networks to ensure higher image quality in real time and improve quality of care through greater clinical accuracy.

Following the completion of the transaction, the start-up will remain an independent company headquartered in France and will continue its growth independently while its products and services will remain compatible with all ultrasound device makers.

Together with Sonio’s expertise, Samsung says its ultrasound systems will help bring to market “AI-enhanced” workflows and accelerate innovation in patient outcomes and quality of prenatal care.

“We have great respect and admiration for what the Sonio team has built in the area of maternal care,” said Yong Kwan Kim, Samsung Medison CEO.

“Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology.

“Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”

Cécile Brosset, Sonio co-founder CEO, added: “Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides.

“We have found in Samsung Medison an amazing, trusting partner to pursue and accelerate our roadmap and mission. In addition to close collaboration with Samsung Medison, as an independent company, Sonio will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare.”

The closing of the transaction is subject to applicable regulatory approvals, and notably the approval of the French Ministry of the Economy and Finance.